Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 8Unknown 4Withdrawn 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Stomatitis 1Neoplasms 1Neoplasm Metastasis 1Lupus Nephritis 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1Inflammation 1Fatigue Syndrome, Chronic 1Bone Neoplasms 1Bites and Stings 1Arthritis, Rheumatoid 1

Interventions

Methotrexate 4veltuzumab 1tocilizumab 1andecaliximab 1Tumor Necrosis Factor Inhibitors 1RC-18 1Nivolumab 1Interleukin 1 Receptor Antagonist Protein 1Folic Acid 1Etanercept 1Bortezomib 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Arthritis, Rheumatoid × Etanercept × Clear all
NCT02109289 2017-02-07

Etanercept in Rheumatoid Arthritis and Vascular Inflammation

Innovaderm Research Inc.

Phase 4 Terminated
5 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡